211 filings
Page 3 of 11
8-K
COEP
Coeptis Therapeutics Holdings Inc
16 Jun 23
Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million
5:15pm
424B4
COEP
Coeptis Therapeutics Holdings Inc
15 Jun 23
Prospectus supplement with pricing info
9:25am
S-1MEF
COEP
Coeptis Therapeutics Holdings Inc
14 Jun 23
Registration of additional securities for an S-1
8:30am
EFFECT
COEP
Coeptis Therapeutics Holdings Inc
14 Jun 23
Notice of effectiveness
12:15am
S-1MEF
COEP
Coeptis Therapeutics Holdings Inc
13 Jun 23
Registration of additional securities for an S-1
9:55pm
CORRESP
COEP
Coeptis Therapeutics Holdings Inc
12 Jun 23
Correspondence with SEC
12:00am
CORRESP
COEP
Coeptis Therapeutics Holdings Inc
12 Jun 23
Correspondence with SEC
12:00am
8-K
COEP
Coeptis Therapeutics Holdings Inc
9 Jun 23
Coeptis Therapeutics Receives Approval to Transfer to The Nasdaq Capital Market
4:15pm
8-K
COEP
Coeptis Therapeutics Holdings Inc
5 Jun 23
Regulation FD Disclosure
6:12pm
8-K
COEP
Coeptis Therapeutics Holdings Inc
17 May 23
Coeptis Therapeutics Appoints Brian Cogley as Chief Financial Officer
4:15pm
10-Q
2023 Q1
COEP
Coeptis Therapeutics Holdings Inc
Quarterly report
15 May 23
4:15pm
10-K
2022 FY
COEP
Coeptis Therapeutics Holdings Inc
Annual report
28 Mar 23
6:02pm
UPLOAD
COEP
Coeptis Therapeutics Holdings Inc
23 Feb 23
Letter from SEC
12:00am
S-1
COEP
Coeptis Therapeutics Holdings Inc
IPO registration
15 Feb 23
6:06am
SC 13G/A
COEP
Coeptis Therapeutics Holdings Inc
15 Feb 23
Coeptis Therapeutics / Harraden Circle Investments ownership change
12:00am
SC 13G/A
Hudson Bay Capital Management LP
6 Feb 23
Coeptis Therapeutics / Hudson Bay Capital Management ownership change
4:25pm